Project Grant K99NS151133
- The National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services National Institutes of Health, awarded $619,189 to Massachusetts Institute of Technology on August 19, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to establish a bioelectronics-integrated mesoscale organ-on-a-chip platform for neuromuscular disease modeling. MIT will develop a limb-on-a-chip platform that...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded Boston Children's Hospital $674,950 on January 16, 2026, to dissect neural circuits that mediate top-down control of sympathetic nervous system functions under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). Boston Children's Hospital will conduct basic neuroscience research analyzing...
- The National Institute of Neurological Disorders and Stroke awarded Dartmouth-Hitchcock Clinic $426,250 on July 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate translaminar interneurons in the spinal cord dorsal horn and their role in the transition from acute to chronic pain. The research combines voltage imaging, electrophysiological, and histological strategies to study excitatory translaminar interneurons in...
- The National Institute of Neurological Disorders and Stroke awarded Beth Israel Deaconess Medical Center, Inc. $283,037 on August 15, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds exploratory research investigating the relationship between meningeal nociception and visual cortex hyperexcitability in migraine pathogenesis. The project employs optogenetic activation of meningeal nociceptors, two-photon calcium...
- The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, awarded Beth Israel Deaconess Medical Center $749,073 on August 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate meningeal sensory neuroimmune interactions underlying migraine headache. The research combines expertise in meningeal nociception and migraine pain with functional interactions between nociceptors...
- The National Institute of Neurological Disorders and Stroke awarded Massachusetts Institute of Technology $651,069 on May 2, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to develop spatially multiplexed imaging techniques for visualizing complex signaling networks in neurons and brain cells. The research advances a method called Signaling Reporter Islands (SIRIs) that enables simultaneous imaging of multiple cellular signals...
- The National Institute of Neurological Disorders and Stroke awarded The Leland Stanford Junior University $423,500 on June 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to dissociate neural representations of pain and salience using intracranial human brain recordings. The research will obtain intracranial electroencephalography (iEEG) measurements in 20 neurosurgical patients as they perform thermal pain and auditory...
- The National Institute of Neurological Disorders and Stroke awarded the University of Massachusetts Medical School $578,007 on August 1, 2026, for research on the gut-brain axis and microbial impact on neural function under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The project investigates mechanistic links between diet, gut microbiota, and neurological disorders including depression, migraine, anxiety, autism, schizophrenia, and...
- The National Institute of Neurological Disorders and Stroke, a component of the Department of Health and Human Services National Institutes of Health, awarded Massachusetts Institute of Technology $436,242 on July 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to support predoctoral training in neuroscience and cognitive science. MIT's Department of Brain and Cognitive Sciences will deliver interdisciplinary graduate training spanning cellular and...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded The Medical University of South Carolina $226,500 on August 21, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to characterize spinal pain and non-pain pathway activity and responses in people with chronic spinal cord injury and neuropathic pain. The research will compare...
The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded Massachusetts Institute of Technology $129,168 on August 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to support research on the modulation of autonomic function by affective pain pathways. The research interrogates the role of the parabrachial-limbic circuit and reciprocal connections between the central amygdala and parabrachial nucleus in autonomic nervous system responses during acute, persistent, and chronic pain states. The work uses computational analysis of neural activity in mouse models to correlate central amygdala neuron activity with behavior and autonomic responses, testing whether different populations of central amygdala neurons differentially modulate autonomic responses and pain behaviors through projections to the parabrachial nucleus. The research aims to establish how autonomic function changes as pain transitions from acute to chronic and to identify parabrachial nucleus neuron populations persistently active during pain states. Performance occurs in Cambridge, Massachusetts, with a period of performance from August 1, 2026, through July 31, 2028. This is a project grant, the standard assistance type for NINDS extramural research funding.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $129.2k | 7/30/26 |